Use of concentrated insulin human regular (U-500) for patients with diabetes-Reference-Cited by-同舟云学术

Use of concentrated insulin human regular (U-500) for patients with diabetes

Published:2010-09-15 Issue:18 Volume:67 Page:1526-1535
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Segal Alissa R.¹,Brunner Jack E.²,Burch F. Taylor³,Jackson Jeffrey A.⁴

Affiliation:

1. Massachusetts College of Pharmacy and Health Sciences, Boston, and Clinical Pharmacist and Diabetes Educator, Joslin Diabetes Center, Boston

2. Endocrine and Diabetes Care Center, Toledo, OH

3. U.S. Medical Division, Endocrine, Lilly USA, LLC, Indianapolis, IN

4. Internal Medicine, School of Medicine, Indiana University, Indianapolis, and Senior Medical Advisor, U.S. Medical Division, Endocrine, Lilly USA, LLC

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/67/18/1526/28345066/ajhp1526.pdf

Reference55 articles.

1. Economic costs of diabetes in the U.S. in 2007;American Diabetes Association;Diabetes Care,2008

2. High dose insulin therapy: is it time for U-500 insulin?;Lane;Endocr Pract,2009

3. Clinical course of genetic diseases of the insulin receptor (Type A and Rabson-Mendenhall syndromes): a 30-year prospective;Musso;Medicine,2004

4. The long term effect of recombinant me-thionyl human leptin (r-metHuLeptin) therapy on hyperandrogenism and menstrual dysfunction in male and female hypoleptinemic lipodystrophic patients;Musso;Metabolism,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prandial Insulins: A Person-Centered Choice;Current Diabetes Reports;2024-04-03

2. Insulin’s Legacy: A Century of Breakthroughs and Innovation;Cardiology in Review;2024-03-13

3. Insulin;Pharmaceutical Biotechnology;2024

4. Significant publications in diabetes pharmacotherapy and technology in 2020;Expert Review of Endocrinology & Metabolism;2023-03-06

5. Significant publications in diabetes pharmacotherapy and technology in 2020;Expert Review of Endocrinology & Metabolism;2023-03-04